Abstract Details

Title Falls During a 10-week Placebo-Controlled Study of Droxidopa for Neurogenic Orthostatic Hypotension in Parkinson’s Disease

Topic Neuromuscular and Clinical Neurophysiology (EMG)

Presentation(s) (-)

Poster/Presentation
Number 283

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Gerry Rowse PRESENTER	No disclosure on file
	No disclosure on file
Arthur L. Hewitt (Amgen Canada Inc.)	No disclosure on file
Shannon Kolind, PhD, MSc, BSc (University of British Columbia)	Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Kolind has received research support from Sanofi Genzyme. The institution of Dr. Kolind has received research support from Roche. The institution of Dr. Kolind has received research support from Biogen.

��ɫ��